Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.

Keum, NaNa; Greenwood, Darren C; Lee, Dong Hoon; Kim, Rockli; Aune, Dagfinn; Ju, Woong; Hu, Frank B; Giovannucci, Edward L
Journal of the National Cancer Institute
2015Mar ; 107 ( 3 ) :.
ÀúÀÚ »ó¼¼Á¤º¸
Keum, NaNa -
Greenwood, Darren C -
Lee, Dong Hoon -
Kim, Rockli -
Aune, Dagfinn -
Ju, Woong -
Hu, Frank B -
Giovannucci, Edward L -
ABSTRACT
BACKGROUND: Adiposity, measured by body mass index, is implicated in carcinogenesis. While adult weight gain has diverse advantages over body mass index in measuring adiposity, systematic reviews on adult weight gain in relation to adiposity-related cancers are lacking.

METHODS: PubMed and Embase were searched through September 2014 for prospective observational studies investigating the relationship between adult weight gain and the risk of 10 adiposity-related cancers. Dose-response meta-analyses were performed using a random-effects model to estimate summary relative risk (RR) and 95% confidence interval (CI) for each cancer type. All statistical tests were two-sided.

RESULTS: A total of 50 studies were included. For each 5kg increase in adult weight gain, the summary relative risk was 1.11 (95% CI = 1.08 to 1.13) for postmenopausal breast cancer among no- or low-hormone replacement therapy (HRT) users, 1.39 (95% CI = 1.29 to 1.49) and 1.09 (95% CI = 1.02 to 1.16) for postmenopausal endometrial cancer among HRT nonusers and users, respectively, 1.13 (95% CI = 1.03 to 1.23) for postmenopausal ovarian cancer among no or low HRT users, 1.09 (95% CI = 1.04 to 1.13) for colon cancer in men. The relative risk of kidney cancer comparing highest and lowest level of adult weight gain was 1.42 (95% CI = 1.11 to 1.81). Adult weight gain was unrelated to cancers of the breast (premenopausal women, postmenopausal HRT users), prostate, colon (women), pancreas, and thyroid. An increase in risk associated with adult weight gain for breast cancer was statistically significantly greater among postmenopausal women (P heterogeneity = .001) and HRT nonusers (P heterogeneity = .001); that for endometrial cancer was alike among HRT nonusers (P heterogeneity = .04).

CONCLUSIONS: Avoiding adult weight gain itself may confer protection against certain types of cancers, particularly among HRT nonusers. CI - ??The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
body weight change; breast cancer; prostate cancer; colon cancer; dose-response meta-analysis; prospective studies
MESH
*Adiposity, Adult, Body Mass Index, Breast Neoplasms/epidemiology/etiology, Colonic Neoplasms/epidemiology/etiology, Endometrial Neoplasms/epidemiology/etiology, Estrogen Replacement Therapy/statistics & numerical data, Female, Humans, Incidence, Male, Neoplasms/*epidemiology/*etiology, Obesity/*complications, Observational Studies as Topic, Ovarian Neoplasms/epidemiology/etiology, Prospective Studies, Prostatic Neoplasms/epidemiology/etiology, Risk Factors, *Weight Gain
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Adult weight reduction may confer protection against certain types of cancers, particularly among HRT nonusers (For each 5kg increase in adult weight gain, the summary relative risk was 1.11 (95% CI = 1.08 to 1.13) for postmenopausal breast cancer among no- or low-hormone replacement therapy (HRT) users)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1093/jnci/dju428
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå